360 Stem Cell & Regenerative Medicine Newsletter - July 22, 2014

 weSRCH's Best of the Internet Award
  24th-Jul-2014
 2084

360 Stem Cell & Regenerative Medicine Newsletter - July 22, 2014

Featured video from The NBC Nightly News with Brian Williams (there is a 30 second commercial preceding the broadcast):
Stemcells' promising news on spinal cord injury, AMD therapies
“As researchers work toward a cure for type 1 diabetes, advances in treatment are improving the quality of life of the thousands of Americans diagnosed each year with the disease. NBC Chief Medical Correspondent Robert Bazell reports.” Editor’s note: The broadcast presents the promise of human embryonic stem cells and features the expertise of Dr. Juan Dominguez-Bendala of the Diabetes Research Institute (DRI), University of Miami Miller School of Medicine.
JDRF partner ViaCyte announces key project milestone to advance innovative encapsulated cell replacement therapy product for type 1 diabetes
ViaCyte filed an Investigational New Drug application (IND) with the U.S. Food and Drug Administration seeking to initiate a Phase 1/2 clinical trial in patients with type-1 diabetes. The trial would evaluate the safety and efficacy of ViaCyte’s product candidate, a stem cell-derived, encapsulated cell replacement therapy. According to a media release from JDRF, “encapsulation therapy overcomes one of the major obstacles that has slowed progress in the islet transplant field, which is the need for lifetime administration of powerful and toxic immunosuppressive drugs to prevent the immune system from destroying the newly introduced islets.”
Duke Medicine: Funding to go toward clinical trials using cord blood stem cells to explore new treatments for autism and other brain disorders
Duke Medicine has been awarded $15 million to support an innovative research program that explores the use of umbilical cord blood cells to treat autism, stroke, cerebral palsy and related brain disorders. The project will consist of a series of clinical trials using umbilical cord blood cells to treat a total of 390 children and adults with autism, 100 children with cerebral palsy and 90 adults with stroke. Duke researchers hypothesize that cord blood may promote repair of dysfunctional or damaged areas of the brain.
UC Davis: 'Support cells' in brain play important role in Down syndrome
Researchers from UC Davis School of Medicine and Shriners Hospitals for Children – Northern California identified a group of cells in the brain that they say plays an important role in the abnormal neuron development in Down syndrome. After developing a new model for studying the syndrome using patient-derived stem cells (iPSC’s), the scientists also found that applying an inexpensive antibiotic to the cells appears to correct many abnormalities in the interaction between the cells and developing neurons. The research was reported in Nature Communications.
Bioscience Technology: Long-awaited, global trial of fetal cells for Parkinson’s
Cynthia Fox reports on some of the promising news relating to Parkinson’s disease presented at the recent meeting of the International Society for Stem Cell Research (ISSCR). In two months, the first of many new PD patients will receive a fetal cell transplant. The transplant will mark the end of a voluntary moratorium by many Western nations after complications arose a decade ago. The new multi-center, open-label, fetal cell TRANSEURO PD trial, sponsored by the EU, is enrolling 150 patients.
Huffington Post: Neostem’s Robin Smith interviews CIRM president, C. Randal Mills
Dr. Mills has his priorities straight. He says, “I came to CIRM to get stem cell treatments to patients in need, and that means focus.”
Bloomberg News: Big news in the world of parthenotes- International Stem Cell should win EU Case, adviser says
Can human parthenotes be patented in the European Union? Likely affirmative. International Stem Cell Corporation should win a court case that may pave the way for a U.K. patent for a procedure to extract stem cells, according to an adviser to the European Union’s top court. The EU’s Court of Justice should rule that the California company’s process based on unfertilized human eggs shouldn’t be considered a human embryo thereby excluding it from an EU ban on patents for such stem-cell research.
StemCells, Inc. announces closing of $20 million offering
StemCells, Inc. is engaged in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery.
Survey: Americans favor expanded cord blood stem cell research
Americans broadly support more stem cell research, according to the results of an online survey released by Cord Blood Registry to coincide with National Cord Blood Awareness Month. The poll included responses from 1,130 individuals to reveal: their belief in the need for continued research to rapidly bring stem cell therapies to the clinic; their level of awareness and understanding of umbilical cord blood as a source of stem cells; and their familiarity with the use of cord blood stem cells in established and experimental therapies. More than 75% believe that cord blood banking is a good investment in their families’ health.
BioNews Texas: Baylor College of Medicine named organizing partner for 10th annual World Stem Cell Summit
BCM was chosen given its reputation for being first in Texas in receiving funding from the National Institutes of Health, and home of the Stem Cells and Regenerative Medicine Center, or STaR, which focuses mainly on the study of both adult stem cells and embryonic stem cells. Current projects at BCM include investigating the role of tumor stem cells in cancer relapses — a project germane to the Summit.

360 Newsletter Editor


Bernard Siegel
Executive Director
Genetics Policy Institute




Stem Cells and the Transformative Power of Hope-a TEDx talk by Bernard Siegel, Editor of 360 Newsletter

About GPI


The nonprofit Genetics Policy Institute (GPI) seeks to establish a positive policy, regulatory and societal framework to enable research to flourish, under the highest ethical and medical standards. We seek to accelerate the discovery and development of lifesaving cures and therapies to alleviate human suffering due to chronic and terminal afflictions. Visit Website.

ConnectGPI on FacebookGPI on TwitterGPI on LinkedIn


Bringing our World Together- the World Stem Cell Summit
Domain: Medical
Category: Biology
SEMICONDUCTOR ANALYTICS

Recent Newsletters

12 March, 2019
10 October, 2018
15 February, 2018